During the past decade, Drug Safety Research Unit (for data collation and analysis only) conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Drug Safety Research Unit (for data collation and analysis only)" #1 collaborator was "Bayer" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Drug Safety Research Unit (for data collation and analysis only)" are "Acute Coronary Syndrome" (1 trials), "Atrial Fibrillation" (1 trials), "Bipolar I Disorder" (1 trials), "Deep Vein Thrombosis" (1 trials) and "Pulmonary Embolism" (1 trials). Many other conditions were trialed in "Drug Safety Research Unit (for data collation and analysis only)" in a lesser frequency.

Most popular intervention types in "Drug Safety Research Unit (for data collation and analysis only)" are "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "This is a non-interventional study" (1 trials). Other intervention names were less common.

The vast majority of trials in "Drug Safety Research Unit (for data collation and analysis only)" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Drug Safety Research Unit (for data collation and analysis only)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Drug Safety Research Unit (for data collation and analysis only), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Drug Safety Research Unit (for data collation and analysis only), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".